Open access · OA via Europe PMC

Menopause timing, hormone therapy, epigenetic aging, and breast cancer outcomes: a secondary analysis of the PLCO Cancer Screening Trial

Authors not listed

medRxiv · 2026

Epigenetic alterations

＋ Sign in to save

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: Europe PMC
Canonical: link ↗
Fetched: 2026-10-26 MST

Cite this

APA

Anonymous. (2026). Menopause timing, hormone therapy, epigenetic aging, and breast cancer outcomes: a secondary analysis of the PLCO Cancer Screening Trial. <em>medRxiv</em>. https://europepmc.org/article/PMC/PMC13692351

Vancouver

Anonymous. Menopause timing, hormone therapy, epigenetic aging, and breast cancer outcomes: a secondary analysis of the PLCO Cancer Screening Trial. medRxiv. 2026.

BibTeX

@article{anon2026Menopa, title = {Menopause timing, hormone therapy, epigenetic aging, and breast cancer outcomes: a secondary analysis of the PLCO Cancer Screening Trial}, author = {Anonymous}, journal = {medRxiv}, year = {2026}, }